Although MALT1 and CARMA1 genetic alterations activating these proteins and activating NF-κB have been found in B-cell lymphomas [32,34,79,80], no mutations affecting the CBM complex in T-ALL have so far been reported. Here, NFKB1 is linked to acute lymphoblastic leukemia.